Kolexia
Francois Bruno Anesthesie-réanimation
Francois Bruno
Anesthesie-réanimation
Hôpital Dupuytren
Limoges, France
235 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sepsie Pneumopathie infectieuse Choc COVID-19 Choc septique Pneumopathie infectieuse sous ventilation assistée Toxémie Maladie grave Urgences

Collaborateurs

Voir plus
Vignon Philippe
Vignon Philippe
Hôpital Dupuytren, Limoges, France
Daix Thomas
Daix Thomas
Hôpital Dupuytren, Limoges, France
Barraud Olivier
Barraud Olivier
Hôpital Dupuytren, Limoges, France
Mercier Emmanuelle
Mercier Emmanuelle
Centre hospitalier de Tours, Tours, France

Industries

Voir plus
GSK
6 collaboration(s)
Dernière en 2021
Cepheid Europe SAS
2 collaboration(s)
Dernière en 2023
Syneos Health, LLC
2 collaboration(s)
Dernière en 2022
INSTITUT MERIEUX
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.: An Exploratory, Multi-Centre, Interventional, Prospective, Randomised, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of AON-D21 in Patients With Severe Community-Acquired Pneumonia.
Essai Clinique (Aptarion Biotech AG)   08 mars 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
Intensive care medicine   04 mars 2024
HAP-DEX: Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype, an International Phase III, Double-blind, Placebo-controlled, Randomized Trial
Essai Clinique (CHU Nantes)   20 février 2024
Along with PaO2/FiO2 ratio and lymphopenia, low HLA-DR monocytes are the only additional parameter that independently predicts the clinical course of undifferentiated SARS-CoV-2 patients in Emergency Departments.
Journal of leukocyte biology   15 février 2024
Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
The Lancet. Respiratory medicine   01 février 2024
AdrenOSS-2: A Double-Blind, Placebo-Controlled, Randomized, Multicenter, Proof of Concept and Dose-Finding Phase II Clinical Trial to Investigate the Safety, Tolerability and Efficacy of ADRECIZUMAB in Patients With Septic Shock and Elevated Adrenomedullin
Essai Clinique (Adrenomed AG)   31 janvier 2024
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
Intensive care medicine   03 janvier 2024
ADAPT: Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Essai Clinique (CHU Limoges)   11 décembre 2023
The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trial.
Journal of critical care   31 octobre 2023
Transient hemi-parkinsonism due to deep brain venous edema induced by severe intracranial hypotension, a case report.
Revue neurologique   07 octobre 2023